HIGHLIGHTS
- who: Qian Shen and collaborators from the Department of Hematologic Lymphoma, Affiliated Cancer Hospital of Nantong University, Nantong, China have published the article: CMTM3 as a Potential New Immune Checkpoint Regulator, in the Journal: Journal of Oncology of 20/09/2022
- what: The authors explore the CMTM3 expression in a variety of cancers and its correlation with the prognosis of cancer patients. This research evaluates the link between CMTM3 and immune activation genes, immunosuppressive genes, immune cell infiltration scores, immune checkpoints, chemokines, and chemokine receptors. This research investigated the function of CMTM3 in various cancer . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.